Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Zealand Pharma's ZP-2307 shows bone anabolic activity in vivo

Oct. 21, 2010

New antibiotics for multidrug-resistant pathogens in preclinical/clinical evaluation

Oct. 21, 2010

Ocrelizumab reduces disease activity in phase II trial in relapsing-remitting MS

Oct. 20, 2010

DepoVax-based vaccination leads to tumor regression in vivo

Oct. 20, 2010

HIV vaccine ALVAC vCP1521 is safe in infants given birth to by HIV-infected women

Oct. 20, 2010

Snapshots: Studies of new antibiotic CB-182804

Oct. 20, 2010

Cancer vaccine CDX-1401 safe and active in ongoing phase I/II trial

Oct. 20, 2010

Levetiracetam does not improve cerebellar symptoms of multiple sclerosis

Oct. 19, 2010

PEGylated opioid analgesic NKTR-181 demonstrates slowed entry into CNS

Oct. 19, 2010

DCVax-L is well tolerated combined with other anticancer agents in ovarian cancer

Oct. 19, 2010

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...